How an Obesity Drug Could Help Alcohol Use Disorder
Promising preclinical and early clinical data suggest a role for GLP-1 receptor agonist therapy in treating alcohol use disorder.
Source: medscape.com
Low Doses News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Low Doses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Low Doses Today - Breaking & Trending Today
Mind Medicine MindMed : Company Logo MindMed Investor Presentation August 2023
Company Logo MindMed Investor Presentation August 2023 Disclaimer This presentation has been prepared by Mind Medicine Inc. solely for informational purposes. None of... -Today at 05:35 pm- MarketScreener
Source: marketscreener.com
Palatin Initiates Clinical Program for Bremelanotide Co-Formulated with a PDE5i for the Treatment of ED in Patients Non-Responsive to PDE5i Treatment
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
Source: prnewswire.com
Diamond Therapeutics to present groundbreaking study at NIH event
Diamond Therapeutics to present groundbreaking study at NIH event News provided by Share this article Share this article Dr. Edward Sellers, head of Diamond's clinical advisory board, will speak about the benefits of low-dose psilocybin TORONTO, May 27, 2021 /PRNewswire/ - Diamond Therapeutics Inc. (" Diamond"), a leading psychedelic drug development company focused on sub-perceptual therapies for mental health, is pleased to announce that the head of its clinical advisory board, Dr. Edward Sellers, will be presenting at the NIH's Psilocybin Research Speaker Series on June 4, 2021. Dr. Selle...
Source: prnewswire.com